Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.8000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.7900/ 2
- Ask / Lots4.9900/ 1
- Open / Previous Close0.0000 / 4.8000
- Day Range---
- 52 Week Range
- Volume984
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 23320 | 4.61 |
| 09:36 ET | 800 | 4.68 |
| 09:38 ET | 1684 | 4.69 |
| 09:39 ET | 3587 | 4.69 |
| 09:41 ET | 2895 | 4.66 |
| 09:45 ET | 1408 | 4.66 |
| 09:48 ET | 12160 | 4.665 |
| 09:50 ET | 2383 | 4.6599 |
| 09:52 ET | 200 | 4.66 |
| 09:54 ET | 2163 | 4.65 |
| 09:56 ET | 725 | 4.665 |
| 09:57 ET | 1600 | 4.695 |
| 09:59 ET | 1400 | 4.71 |
| 10:01 ET | 1841 | 4.71 |
| 10:03 ET | 1705 | 4.7 |
| 10:06 ET | 13741 | 4.76 |
| 10:08 ET | 15073 | 4.83 |
| 10:10 ET | 7783 | 4.81 |
| 10:12 ET | 22063 | 4.87 |
| 10:14 ET | 22676 | 4.9 |
| 10:15 ET | 22863 | 4.8999 |
| 10:17 ET | 13592 | 4.94 |
| 10:19 ET | 21882 | 4.955 |
| 10:21 ET | 14350 | 4.93 |
| 10:24 ET | 20143 | 5.01 |
| 10:26 ET | 24387 | 5.03 |
| 10:28 ET | 32114 | 5.06 |
| 10:30 ET | 15400 | 5.03 |
| 10:32 ET | 11505 | 5.05 |
| 10:33 ET | 18539 | 5.0349 |
| 10:35 ET | 18402 | 5.07 |
| 10:37 ET | 15920 | 5.06 |
| 10:39 ET | 16791 | 5.03 |
| 10:42 ET | 17455 | 4.9122 |
| 10:44 ET | 5786 | 4.93 |
| 10:46 ET | 3059 | 4.955 |
| 10:48 ET | 3391 | 4.935 |
| 10:50 ET | 107199 | 4.9 |
| 10:51 ET | 11405 | 4.865 |
| 10:53 ET | 3674 | 4.885 |
| 10:55 ET | 16396 | 4.84 |
| 10:57 ET | 1340 | 4.85 |
| 11:00 ET | 2400 | 4.835 |
| 11:02 ET | 368 | 4.85 |
| 11:04 ET | 1816 | 4.855 |
| 11:06 ET | 9097 | 4.9 |
| 11:08 ET | 9716 | 4.9 |
| 11:09 ET | 3840 | 4.89 |
| 11:11 ET | 800 | 4.885 |
| 11:13 ET | 3576 | 4.915 |
| 11:15 ET | 6236 | 4.92 |
| 11:18 ET | 535 | 4.91 |
| 11:20 ET | 754 | 4.92 |
| 11:22 ET | 500 | 4.925 |
| 11:24 ET | 4613 | 4.92 |
| 11:26 ET | 2488 | 4.925 |
| 11:27 ET | 13585 | 4.91 |
| 11:29 ET | 984 | 4.905 |
| 11:31 ET | 9779 | 4.885 |
| 11:33 ET | 3518 | 4.93 |
| 11:36 ET | 1350 | 4.925 |
| 11:38 ET | 4581 | 4.946 |
| 11:40 ET | 46047 | 4.92 |
| 11:42 ET | 2901 | 4.9 |
| 11:44 ET | 2750 | 4.895 |
| 11:45 ET | 584 | 4.905 |
| 11:47 ET | 1500 | 4.9 |
| 11:49 ET | 600 | 4.9 |
| 11:51 ET | 200 | 4.895 |
| 11:54 ET | 4769 | 4.89 |
| 11:56 ET | 1200 | 4.875 |
| 11:58 ET | 2648 | 4.874 |
| 12:00 ET | 2112 | 4.895 |
| 12:02 ET | 1413 | 4.895 |
| 12:03 ET | 700 | 4.905 |
| 12:05 ET | 5027 | 4.88 |
| 12:07 ET | 1950 | 4.9 |
| 12:09 ET | 19305 | 4.895 |
| 12:12 ET | 13407 | 4.87 |
| 12:14 ET | 7162 | 4.84 |
| 12:16 ET | 4421 | 4.83 |
| 12:18 ET | 16466 | 4.82 |
| 12:20 ET | 6512 | 4.815 |
| 12:21 ET | 5581 | 4.78 |
| 12:23 ET | 6005 | 4.79 |
| 12:25 ET | 4041 | 4.78 |
| 12:27 ET | 10472 | 4.775 |
| 12:30 ET | 3800 | 4.8 |
| 12:32 ET | 2200 | 4.82 |
| 12:34 ET | 8751 | 4.84 |
| 12:36 ET | 5367 | 4.86 |
| 12:38 ET | 3054 | 4.86 |
| 12:39 ET | 700 | 4.87 |
| 12:41 ET | 1386 | 4.87 |
| 12:43 ET | 15384 | 4.905 |
| 12:45 ET | 6074 | 4.925 |
| 12:48 ET | 3400 | 4.9 |
| 12:50 ET | 4034 | 4.9295 |
| 12:52 ET | 100 | 4.93 |
| 12:54 ET | 500 | 4.9299 |
| 12:56 ET | 3887 | 4.915 |
| 12:57 ET | 1611 | 4.925 |
| 12:59 ET | 700 | 4.925 |
| 01:01 ET | 21616 | 4.84 |
| 01:03 ET | 1800 | 4.87 |
| 01:06 ET | 2825 | 4.85 |
| 01:08 ET | 7512 | 4.86 |
| 01:10 ET | 6649 | 4.825 |
| 01:12 ET | 4228 | 4.84 |
| 01:14 ET | 800 | 4.845 |
| 01:15 ET | 4955 | 4.835 |
| 01:17 ET | 3619 | 4.845 |
| 01:19 ET | 11252 | 4.805 |
| 01:21 ET | 1600 | 4.82 |
| 01:24 ET | 19916 | 4.825 |
| 01:26 ET | 6685 | 4.78 |
| 01:28 ET | 7418 | 4.765 |
| 01:30 ET | 19347 | 4.73 |
| 01:32 ET | 9691 | 4.75 |
| 01:33 ET | 6202 | 4.72 |
| 01:35 ET | 8903 | 4.725 |
| 01:37 ET | 12056 | 4.71 |
| 01:39 ET | 2824 | 4.71 |
| 01:42 ET | 5126 | 4.7 |
| 01:44 ET | 2211 | 4.705 |
| 01:46 ET | 4634 | 4.7 |
| 01:48 ET | 4010 | 4.7 |
| 01:50 ET | 12424 | 4.705 |
| 01:51 ET | 18623 | 4.755 |
| 01:53 ET | 12895 | 4.76 |
| 01:55 ET | 2900 | 4.73 |
| 01:57 ET | 600 | 4.745 |
| 02:00 ET | 3452 | 4.725 |
| 02:02 ET | 2604 | 4.72 |
| 02:04 ET | 17501 | 4.77 |
| 02:06 ET | 844 | 4.775 |
| 02:08 ET | 2499 | 4.775 |
| 02:09 ET | 500 | 4.77 |
| 02:11 ET | 3634 | 4.785 |
| 02:13 ET | 400 | 4.785 |
| 02:15 ET | 200 | 4.785 |
| 02:18 ET | 1068 | 4.785 |
| 02:20 ET | 800 | 4.79 |
| 02:22 ET | 22837 | 4.785 |
| 02:24 ET | 4817 | 4.82 |
| 02:26 ET | 9239 | 4.82 |
| 02:27 ET | 100 | 4.82 |
| 02:31 ET | 300 | 4.83 |
| 02:33 ET | 1500 | 4.825 |
| 02:36 ET | 4729 | 4.815 |
| 02:38 ET | 454 | 4.815 |
| 02:40 ET | 1100 | 4.825 |
| 02:42 ET | 2402 | 4.815 |
| 02:45 ET | 200 | 4.81 |
| 02:47 ET | 1505 | 4.83 |
| 02:49 ET | 500 | 4.83 |
| 02:51 ET | 404 | 4.83 |
| 02:54 ET | 1408 | 4.83 |
| 02:56 ET | 600 | 4.825 |
| 02:58 ET | 13839 | 4.82 |
| 03:00 ET | 1500 | 4.825 |
| 03:02 ET | 4130 | 4.81 |
| 03:03 ET | 4984 | 4.805 |
| 03:05 ET | 2300 | 4.8 |
| 03:07 ET | 1200 | 4.81 |
| 03:09 ET | 12175 | 4.795 |
| 03:12 ET | 1552 | 4.7861 |
| 03:14 ET | 1474 | 4.795 |
| 03:16 ET | 800 | 4.795 |
| 03:18 ET | 1211 | 4.795 |
| 03:20 ET | 910 | 4.79 |
| 03:21 ET | 4284 | 4.785 |
| 03:23 ET | 400 | 4.79 |
| 03:25 ET | 1870 | 4.8 |
| 03:27 ET | 1100 | 4.795 |
| 03:30 ET | 8431 | 4.775 |
| 03:32 ET | 26880 | 4.78 |
| 03:34 ET | 13323 | 4.755 |
| 03:36 ET | 9141 | 4.72 |
| 03:38 ET | 10263 | 4.73 |
| 03:39 ET | 8947 | 4.73 |
| 03:41 ET | 7796 | 4.74 |
| 03:43 ET | 23091 | 4.75 |
| 03:45 ET | 18912 | 4.715 |
| 03:48 ET | 25679 | 4.72 |
| 03:50 ET | 32272 | 4.76 |
| 03:52 ET | 21599 | 4.8 |
| 03:54 ET | 27361 | 4.79 |
| 03:56 ET | 34724 | 4.77 |
| 03:57 ET | 42568 | 4.81 |
| 03:59 ET | 251865 | 4.8 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.4B | -3.1x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.9x | --- |
Iovance Biotherapeutics Inc | 3.0B | -6.0x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.1x | --- |
Biohaven Ltd | 3.0B | -4.9x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
